BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:19 PM
 | 
Apr 29, 2009
 |  BC Extra  |  Company News

sanofi returns TroVax rights

sanofi-aventis Group (Euronext:SAN; NYSE:SNY) returned to Oxford BioMedica plc (LSE:OXB) rights to TroVax following a review of the pharma's R&D portfolio (see below). Oxford will receive a $16.5 million payment. Last year,...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >